Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AptarGroup, Inc. Common Stock (NY:ATR)

118.60 +0.72 (+0.61%)
Streaming Delayed Price Updated: 3:18 PM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AptarGroup, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot ↗
AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance and... 
Via MarketBeat
News headline image
AptarGroup (ATR) Q1 2026 Earnings Transcript ↗
AptarGroup (ATR) Q1 2026 Earnings Transcript 
Via The Motley Fool
AptarGroup Q1 2026: Pharma Destocking Drags Earnings as Core Sales Stall for NYSE:ATR ↗
Via Chartmill
News headline image
Aptar Reports First Quarter 2026 Results
From AptarGroup, Inc.
Via Business Wire
AptarGroup Inc (NYSE:ATR) Beats Q4 Revenue Estimates, Issues Cautious Q1 Outlook ↗
Via Chartmill
News headline image
Earnings Scheduled For October 30, 2025 ↗
 
Via Benzinga
News headline image
Boston Trust Walden Lets Go of 93,000 Qualys (QLYS) Shares ↗
Qualys delivers cloud-based security and compliance solutions to enterprise and public sector clients across multiple industries. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Aptar Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Recognized as One of America’s Climate Leaders by USA Today for the Fourth Consecutive Year
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
From Aptar Digital Health
Via Business Wire
News headline image
Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year
From AptarGroup, Inc.
Via Business Wire
News headline image
End of an Era: West Pharmaceutical Shares Slide as Longtime CEO Eric Green Announces Retirement
Shares of West Pharmaceutical Services (NYSE: WST) tumbled 5.7% on Tuesday following the announcement that Eric Green, the company’s President, Chief Executive Officer, and Chair of the Board, intends... 
Via MarketMinute
Topics Economy Retirement
News headline image
River Road Loads Up on ATR With 917,000 Shares in New Position ↗
AptarGroup delivers proprietary dispensing and sealing solutions to global healthcare, beauty, and consumer markets. 
Via The Motley Fool
Topics Emissions
News headline image
Aptar to Participate in Upcoming Investor Conferences
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Reports Fourth Quarter and Annual 2025 Results
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Announces 2026 Quarterly Conference Call Dates
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy® with Oura Ring
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
From AptarGroup, Inc.
Via Business Wire
News headline image
Picks and Shovels of the Biotech Revolution: A Deep Dive into West Pharmaceutical Services (WST)
Date: December 23, 2025 Introduction In the high-stakes world of biotechnology and pharmaceutical manufacturing, few companies are as indispensable yet as quietly influential as West Pharmaceutical... 
Via PredictStreet
Topics Economy Intellectual Property Supply Chain
News headline image
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
From Aptar Group, Inc.
Via Business Wire
News headline image
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Reports Third Quarter 2025 Results
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers
From Aptar Digital Health
Via Business Wire
News headline image
Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes
From AptarGroup, Inc.
Via Business Wire
News headline image
Top 3 Materials Stocks That May Rocket Higher In Q3 ↗
 
Via Benzinga
News headline image
Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength
From AptarGroup, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.